New blood test could replace risky prenatal procedures for genetic diseases
NCT ID NCT07469657
First seen Mar 16, 2026 · Last updated Apr 30, 2026 · Updated 7 times
Summary
This study looks at whether a new, non-invasive blood test using next-generation sequencing can replace current invasive methods (like amniocentesis) for detecting severe genetic diseases in unborn babies. Researchers will compare the costs and benefits of this new test with standard care in 300 couples at risk. The goal is to see if the new test is cheaper, safer, and easier to use widely.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENETIC DISEASES, INBORN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpital Necker Enfants Malades
Paris, Île-de-France Region, 75015, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.